Skip to main content

Day: March 19, 2025

Zoomcar Holdings, Inc. Announces 1-for-20 Reverse Stock Split

Bangalore, India, March 19, 2025 (GLOBE NEWSWIRE) — Zoomcar Holdings, Inc. (Nasdaq: ZCAR) (“Zoomcar” or the “Company”),  a Nasdaq-listed leading marketplace for self-drive car sharing, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, at a ratio of 1-for-20. The reverse stock split will become effective at 4:30 p.m. Eastern Time on March 21, 2025, and the Company’s common stock will begin trading on a split-adjusted basis when the market opens on March 24, 2025. The Company’s common stock will continue to trade on the Nasdaq Global Market (“Nasdaq”) under the symbol “ZCAR.” The new CUSIP number for the Company’s common stock following the reverse stock split will be 45784G309. At the Company’s special meeting of stockholders held on February...

Continue reading

Wearable Devices Announces Full Year 2024 Financial Results and Provides Corporate Update

YOKNE’AM ILLIT, Israel, March 19, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced its financial results for the year ended December 31, 2024. Asher Dahan, Chief Executive Officer and Chairman of the Board of Directors of Wearable Devices, commented, “2024 was characterized by strategic capital allocation and the execution of our growth strategy as we delivered our Mudra Band for Apple Watch, and entered into several collaborations with companies and contractors at the forefront of their respective industries. With a strong focus on technological breakthroughs and innovation, we introduced the Mudra Link, a universal gesture control wearable...

Continue reading

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International. Emergent received approximately $36.5 million at closing, which is subject to customary post-closing adjustments. Pursuant to the sale, Syngene acquired the assets and equipment associated with the Baltimore-Bayview facility. In addition, Emergent retains the rights to secure manufacturing services and capacity at the facility for future growth and pandemic response production in collaboration with Syngene. “This deal enables us to streamline operations, while maintaining flexibility for future product demand.” said Joe Papa, president and CEO of Emergent. “As we continue our multi-year transformation, we...

Continue reading

CVB Financial Corp. Announces 142nd Consecutive Quarterly Cash Dividend

Ontario, CA, March 19, 2025 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the first quarter of 2025. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on March 19, 2025. The quarterly dividend will be payable on or about April 16, 2025 to shareholders of record as of April 2, 2025. “We are pleased to announce our 142nd consecutive quarterly cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate OverviewCVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with greater than $15 billion in total assets. Citizens Business Bank is...

Continue reading

STMicroelectronics announces resignation of a member of Supervisory Board

STMicroelectronics announces resignation of a member of Supervisory Board Amsterdam, March 19, 2025 – STMicroelectronics (NYSE:STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announces that Maurizio Tamagnini is resigning from ST’s Supervisory Board, effective immediately. Maurizio Tamagnini was first elected to ST’s Supervisory Board in 2014 and served as Chairman and Vice-Chairman during his tenure. He was Vice-Chairman since 2023. Nicolas Dufourcq, Chairman of ST’s Supervisory Board, expressed his thanks to Maurizio Tamagnini on behalf of the Supervisory Board for his long-term support.                  About STMicroelectronicsAt ST, we are 50,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities....

Continue reading

Stack Capital Group Inc. Announces Supplemental Listing of Warrants

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 19, 2025 (GLOBE NEWSWIRE) — Stack Capital Group Inc. (“Stack Capital” or the “Company”) (TSX: STCK) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted for listing 757,948 common share purchase warrants of the Company (the “Warrants”). The Warrants were previously issued on a private placement basis, in two tranches, as part of the issuance of a total of 1,515,908 units of Stack Capital, each unit consisting of one common share and one-half of one Warrant, which closed on October 30, 2024, and November 22, 2024. The TSX has advised that the Warrants (CUSIP 85236X153; ISIN CA85236X1539) will be listed for trading on the TSX under the symbol “STCK.WT.A” effective at market open...

Continue reading

Epsilon Announces Full Year 2024 Results

HOUSTON, March 19, 2025 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported financial results for the fourth quarter and full-year ended December 31, 2024. Full Year and Q4 2024 Highlights:Epsilon – Full Year 2024 & Q4 2024    2024 2023 Q4 2024 Q3 2024 YoY% QoQ%NRI Production              Gas MMcf 6,142 8,340 1,765 1,304 -26% 35%Oil Mbbl 187 65 52 53 186% -3%NGL Mbbl 69 39 17 17 78% -2%Total Mmcfe 7,676 8,965 2,176 1,727 -14% 26%               Revenues $M            Gas   10,786 14,864 3,958 1,904 -27% 108%Oil   13,731 5,091 3,537 3,965 170% -11%NGL   1,482 984 385 335 51% 15%Midstream1   5,524 9,791 1,060 1,084 -44% -2%Total   31,523 30,730 8,940 7,288 3% 23%               Realized Prices2              Gas $/Mcf 1.76 1.78 2.24 1.46 -1% 54%Oil $/Bbl 73.61 77.96 68.38 74.27 -6% -8%NGL $/Bbl 21.41 25.29 22.98 19.56 -15% 17%               Adj....

Continue reading

Galecto Reports Full-Year 2024 Financial Results

Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets of AML from Bridge Medicines GB3226 on track for IND submission in Q1 2026 Phase 2 investigator-initiated trial (IIT) of GB1211 in combination with pembrolizumab (Keytruda®) in metastatic melanoma and head and neck squamous cell carcinoma continues to enroll patientsBOSTON, March 19, 2025 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced its operating and financial results for the quarter and year ended December 31, 2024. “A significant moment for Galecto in 2024 was the completion of our strategic review,...

Continue reading

Team, Inc. Reports Fourth Quarter and Full Year 2024 Results

SUGAR LAND, Texas, March 19, 2025 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights:Generated fourth quarter 2024 revenues of $213.3 million. Grew gross margin to $57.3 million, up 330 basis points compared to the prior year period to 26.9% of consolidated revenue. Reported net loss of $7.2 million, a $15.9 million improvement from the 2023 period. Improved consolidated Adjusted EBITDA1 to $14.6 million (6.9% of consolidated revenue), up 50.5% from $9.7 million (4.5% of consolidated...

Continue reading

EZCORP Announces Termination of Acquisition Agreement

AUSTIN, Texas, March 19, 2025 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW) (the “Company”), a leading provider of pawn loans in the United States and Latin America, announced today that it has terminated its definitive agreement with Presta Dinero, S.A. de C.V. for the purchase of 53 stores in Mexico, which was entered into on September 10, 2024. Lachie Given, EZCORP Chief Executive Officer, stated, “While the termination of the present transaction is unfortunate, we remain excited about our expansion opportunities in Mexico. We currently operate over 560 stores across Mexico and continue to grow our footprint through opening de novo stores, while maintaining our disciplined pursuit of opportunistic acquisitions.” ABOUT EZCORP Formed in 1989, EZCORP has grown into a leading provider of pawn transactions in the United States and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.